Antibodies against p24 of HIV-1 in patients with systemic lupus erythematosus? NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Antibodies against p24 of HIV-1 in patients with systemic lupus erythematosus?

Viral Immunol. 1992 Fall;5(3):229-31. Unique Identifier : AIDSLINE MED/93039297
Herrmann M; Baur A; Nebel-Schickel H; Vornhagen R; Jahn G; Krapf FE; Kalden JR; Department of Medicine III, University Erlangen, Germany.

Abstract: The involvement of retroviruses in the etiopathogenesis of autoimmunity is discussed. Recently antibodies against p24 of HIV-1 were described in patients from Texas with SLE. Therefore we investigated the presence of these antibodies in our SLE collective (German caucasians and blacks from Michigan) employing ELISA and Western blot. No anti-p24 reactivity was observed in our SLE patients in Western blots, suggesting that there may be ethnological or regional differences between our patients those from Texas.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Arthritis, Rheumatoid/IMMUNOLOGY Autoimmunity/IMMUNOLOGY AIDS-Related Complex/IMMUNOLOGY Blotting, Western Caucasoid Race Enzyme-Linked Immunosorbent Assay Germany Human HIV Antibodies/*IMMUNOLOGY HIV Antigens/IMMUNOLOGY HIV Core Protein p24/*IMMUNOLOGY HIV-1/*IMMUNOLOGY Lupus Erythematosus, Systemic/ETHNOLOGY/*IMMUNOLOGY Michigan Negroid Race JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/immunologyarthritis,rheumatoid/immunologyautoimmunity/immunologyaids-relatedcomplex/immunologyblotting,westerncaucasoidraceenzyme-linkedimmunosorbentassaygermanyhumanhivantibodies/KWDimmunologyhivantigens/immunologyhivcoreproteinp24/KWDimmunologyhiv-1/KWDimmunologylupuserythematosus,systemic/ethnology/KWDimmunologymichigannegroidracejournalarticle
930228
M9320839

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .